Epidemiological, Clinical, and Therapeutic Profile of Uveitis in Patients With MS
abstract
This abstract is available on the publisher's site.
Access this abstract nowINTRODUCTION
Uveitis may occur during approximately 1-3% of MS patients, corresponding to 10 times higher than in the general population. The development of uveitis is not currently considered as an inflammatory relapse of MS. There are no clinical guidelines for treating. MS with concomitant uveitis requiring systemic treatment.
PURPOSES
To analyze clinical and therapeutic characteristics of uveitis in patients with MS and the impact of MS treatment on the progression of uveitis.
MATERIALS & METHODS
We conducted a retrospective, observational, multicenter study in France about 54 patients.
RESULTS
The form of MS most frequently associated with uveitis in our study was the relapsing-remitting form (85%). The mean time of onset of uveitis was 15 months before the diagnosis of MS. The most frequent form of uveitis was bilateral panuveitis (43%), non-granulomatous (61%), synechial (52%) and non-hypertonic (93%) with progressive onset (65%) and chronic course (66%).
CONCLUSION
MS-associated uveitis occurs most frequently before the diagnosis of relapsing-remitting MS in the form of panuveitis or intermediate uveitis, which is mildly inflammatory and whose main complications are macular edema, cataract and venous vasculitis. Despite their chronicity, these uveitis cases have a good visual prognosis and teriflunomide appears to have a positive effect on progression.
Click on any of these tags to subscribe to Topic Alerts. Once subscribed, you can get a single, daily email any time PracticeUpdate publishes content on the topics that interest you.
Visit your Preferences and Settings section to Manage All Topic Alerts
Additional Info
Disclosure statements are available on the authors' profiles:
Epidemiological, Clinical, and Therapeutic Profile of Uveitis in Multiple Sclerosis: A Multicenter Study
Ocul Immunol Inflamm 2024 Apr 11;[EPub Ahead of Print], R Fitoussi, P Gascon, D Denis, T Mathis, N Tieulé, C Schneider-Rouhaud, R Attia, T David, N StolowyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.